NATCO Pharma’s Stock Falls 19% on their Q3 2025 Results
Shares of NATCO Pharma fell 19% after a dismal Q3 FY25 report that revealed a 37.75% decline in profits, indicating further difficulties in their export formulation sector. Natco Pharma Shares Tank 19% Post Q3 Earnings: On Thursday, February 13, NATCO Pharma’s stock fell 19% after the company revealed its third-quarter fiscal 2024–25 (Q3 FY25) results, […]
NATCO Pharma’s Stock Falls 19% on their Q3 2025 Results Read More »